Drug Shortage Report for PMS-RABEPRAZOLE EC

Last updated on 2022-03-04 History
Report ID 149260
Drug Identification Number 02310805
Brand name PMS-RABEPRAZOLE EC
Common or Proper name RABEPRAZOLE EC
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 10MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-14
Estimated end date 2023-01-01
Actual end date
Shortage status Actual shortage
Updated date 2022-03-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-03-04 French Compare
v5 2022-03-04 English Compare
v4 2022-01-17 French Compare
v3 2022-01-17 English Compare
v2 2021-11-15 French Compare
v1 2021-11-15 English Compare

Showing 1 to 6 of 6